Serum Lactate Dehydrogenase Level is a Prognostic Factor in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy

Author： Turen Selahattin   Ozyar Enis   Altundag Kadri   Gullu Ibrahim   Atahan Ibtisam L.  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.25, Iss.5, 2007-07, pp. : 315-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The long‐term outcomes of alternating chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multiinstitutional phase II study

By  

Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. : 1186-1195

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II trial of concurrent chemoradiotherapy with S1 versus weekly cisplatin for locoregionally advanced nasopharyngeal carcinoma

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 687-691

Science Publishers

Access to resources Recommend Favorite

Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma

By      

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1123-1130

Spandidos Publications

Access to resources Recommend Favorite

Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy

By          

Oncology Letters, Vol. 7, Iss. 4, 2014-01 ,pp. : 1118-1122

Spandidos Publications

Access to resources Recommend Favorite

Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy

By                    

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 706-712

Science Publishers

Access to resources Recommend Favorite